PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 211 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,066,000 | +30.8% | 208,471 | +14.5% | 0.56% | +29.6% |
| Q1 2019 | $6,929,000 | -28.2% | 182,044 | -18.9% | 0.43% | -26.9% |
| Q4 2018 | $9,652,000 | -49.5% | 224,360 | -42.4% | 0.59% | -33.7% |
| Q3 2018 | $19,129,000 | +47.0% | 389,199 | -4.1% | 0.89% | +45.9% |
| Q2 2018 | $13,014,000 | +29.4% | 406,050 | +25.8% | 0.61% | +23.9% |
| Q1 2018 | $10,056,000 | -17.7% | 322,821 | +20.6% | 0.49% | -8.2% |
| Q4 2017 | $12,222,000 | +19.9% | 267,742 | -1.3% | 0.54% | +28.7% |
| Q3 2017 | $10,191,000 | -12.4% | 271,404 | +11.3% | 0.42% | -15.0% |
| Q2 2017 | $11,632,000 | +16.0% | 243,860 | +10.9% | 0.49% | +18.3% |
| Q1 2017 | $10,025,000 | +95.6% | 219,846 | +38.6% | 0.42% | +94.4% |
| Q4 2016 | $5,124,000 | +100.0% | 158,631 | +111.9% | 0.21% | +94.5% |
| Q3 2016 | $2,562,000 | – | 74,854 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |